MediCann

MediCann is a pioneer in the medical cannabis space, founded in 2004 by Dr. Jean Talleyrand. Headquartered in San Francisco, California, the company operates as a medical cannabis intermediary, clinic network, and education provider. MediCann has provided medical cannabis evaluations and consultations to over 300,000 patients across California, helping them navigate the therapeutic use of cannabis for conditions such as chronic pain, insomnia, cancer, and anxiety. In addition to patient care, MediCann collaborates with research organizations like the Clinical Endocannabinoid System Consortium (CESC) on initiatives such as The Dosing Project™ to advance the scientific understanding of cannabis dosing and efficacy.